Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Curanex Pharmaceuticals Inc (CURX) had Pre-Tax Income of $-2.82M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
-- |
|
$-2.82M |
|
-- |
|
-- |
|
$2.83M |
|
$-2.83M |
|
$0.01M |
|
|
Pre-Tax Income |
$-2.82M |
$-2.82M |
|
$-2.82M |
|
$-2.82M |
|
$-2.82M |
|
$-2.82M |
|
$-2.83M |
|
$-2.79M |
|
1.52M |
|
1.52M |
|
$-1.86 |
|
$-1.86 |
|
| Balance Sheet Financials | |
$2.56M |
|
-- |
|
$0.54M |
|
$3.10M |
|
$0.14M |
|
-- |
|
$0.41M |
|
$0.55M |
|
$2.55M |
|
$2.55M |
|
$2.55M |
|
1.57M |
|
| Cash Flow Statement Financials | |
$-3.39M |
|
-- |
|
-- |
|
$4.97M |
|
$1.58M |
|
$-3.39M |
|
$0.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.84 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-110.63% |
|
-110.62% |
|
-90.91% |
|
-110.62% |
|
$1.62 |
|
$-2.24 |
|
$-2.24 |
|